URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Schell

Concepts (268)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Radiosurgery
17
1994
74
3.130
Why?
Brachytherapy
20
1985
111
2.030
Why?
Brain Neoplasms
9
1997
281
1.250
Why?
Radiotherapy Dosage
27
1979
203
0.970
Why?
Central Nervous System
1
2011
113
0.720
Why?
Radiotherapy Planning, Computer-Assisted
10
1987
48
0.710
Why?
Lung Neoplasms
7
1994
439
0.670
Why?
Radiotherapy
5
1990
198
0.600
Why?
Iodine Radioisotopes
9
1985
100
0.580
Why?
Prostatic Neoplasms
8
1985
555
0.530
Why?
Carcinoma, Squamous Cell
2
1984
236
0.490
Why?
Radiometry
5
1982
40
0.460
Why?
Dose Fractionation
6
2001
60
0.450
Why?
Adenocarcinoma
1
2006
439
0.420
Why?
Stents
3
1999
129
0.400
Why?
Humans
57
1979
36274
0.370
Why?
Fast Neutrons
8
1979
10
0.360
Why?
Beta Particles
1
1999
6
0.360
Why?
Algorithms
4
1996
541
0.350
Why?
Neutrons
5
1979
8
0.340
Why?
Coronary Vessels
2
1999
132
0.340
Why?
Blood Vessels
1
1999
92
0.320
Why?
Radiotherapy, High-Energy
6
1980
24
0.300
Why?
Ear Neoplasms
1
1996
6
0.290
Why?
Professional Staff Committees
3
2001
7
0.290
Why?
Neurilemmoma
1
1996
18
0.290
Why?
Radiation Oncology
3
2001
18
0.290
Why?
Pancreatic Neoplasms
2
1991
82
0.280
Why?
Particle Accelerators
5
1982
13
0.280
Why?
Aged, 80 and over
10
2002
2529
0.280
Why?
Vestibule, Labyrinth
1
1996
82
0.270
Why?
Pituitary Neoplasms
1
1995
66
0.260
Why?
Tunica Intima
3
1998
84
0.250
Why?
Male
29
1982
19675
0.250
Why?
Research Design
3
2001
336
0.240
Why?
Middle Aged
16
1982
9837
0.230
Why?
Brain Diseases
2
1990
132
0.220
Why?
Aged
15
1982
7269
0.220
Why?
Radiotherapy, Computer-Assisted
3
1987
15
0.220
Why?
Treatment Outcome
8
2001
2615
0.220
Why?
Feasibility Studies
4
1999
202
0.210
Why?
Stereotaxic Techniques
2
1990
33
0.210
Why?
Glioblastoma
3
1982
63
0.210
Why?
Chemoprevention
1
2011
12
0.200
Why?
Neoplasms
4
1979
739
0.200
Why?
Radiation Dosage
5
1979
125
0.190
Why?
Vascular Surgical Procedures
2
2000
65
0.190
Why?
Adult
15
1982
11351
0.190
Why?
Neoplasm Metastasis
2
2008
228
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2003
429
0.180
Why?
Patient Selection
1
2011
212
0.180
Why?
Treatment Failure
2
2006
128
0.170
Why?
Thoracic Neoplasms
1
2009
19
0.170
Why?
Liver Neoplasms
2
2006
151
0.170
Why?
Mathematics
2
1979
149
0.170
Why?
Carotid Stenosis
2
1999
51
0.160
Why?
Female
20
1982
19838
0.160
Why?
Monte Carlo Method
4
1987
58
0.160
Why?
Tomography, X-Ray Computed
5
1987
759
0.150
Why?
Practice Guidelines as Topic
1
2010
302
0.150
Why?
Muscle, Smooth, Vascular
2
2000
347
0.150
Why?
Survival Analysis
2
2006
606
0.150
Why?
Glioma
1
2008
102
0.150
Why?
Paclitaxel
2
2003
58
0.140
Why?
Cisplatin
2
2003
95
0.140
Why?
Antineoplastic Protocols
1
2006
3
0.140
Why?
Hyperplasia
6
1998
92
0.140
Why?
Antineoplastic Agents
1
2011
619
0.130
Why?
Magnetic Resonance Imaging
4
1996
991
0.130
Why?
Retrospective Studies
5
2006
2267
0.130
Why?
Prochlorperazine
1
2005
11
0.130
Why?
Ondansetron
1
2005
11
0.130
Why?
Biophysical Phenomena
4
1994
51
0.130
Why?
Radiotherapy, Conformal
2
2001
19
0.130
Why?
Biophysics
4
1994
61
0.130
Why?
Dose-Response Relationship, Radiation
8
1980
219
0.130
Why?
Antiemetics
1
2005
56
0.120
Why?
Decision Theory
3
1997
7
0.120
Why?
Vomiting
1
2005
115
0.120
Why?
Postoperative Care
1
2004
126
0.120
Why?
Dexamethasone
1
2005
181
0.120
Why?
Film Dosimetry
3
1979
6
0.120
Why?
Palladium
3
1996
15
0.120
Why?
Models, Structural
4
1987
51
0.120
Why?
Nausea
1
2005
155
0.110
Why?
Ifosfamide
1
2003
8
0.110
Why?
Catheterization
3
1998
125
0.110
Why?
Photogrammetry
1
2003
3
0.110
Why?
Carcinoma, Small Cell
1
2003
32
0.110
Why?
Radiation Protection
3
1987
23
0.110
Why?
Immobilization
1
2003
28
0.110
Why?
Peripheral Vascular Diseases
1
2002
28
0.110
Why?
United States
4
1999
2688
0.110
Why?
Imaging, Three-Dimensional
1
2003
89
0.100
Why?
Radiation Injuries
5
1984
131
0.100
Why?
Blood Vessel Prosthesis Implantation
1
2001
51
0.100
Why?
Image Enhancement
1
2003
145
0.100
Why?
Breast Neoplasms
2
2004
673
0.100
Why?
Carotid Arteries
2
1998
100
0.100
Why?
Radioisotopes
2
1996
47
0.090
Why?
Prostatic Diseases
1
2000
9
0.090
Why?
Models, Biological
3
1990
1008
0.090
Why?
Cobalt Radioisotopes
2
1979
17
0.090
Why?
Computer Simulation
2
1999
302
0.090
Why?
Models, Theoretical
4
1979
192
0.090
Why?
Calibration
1
1999
44
0.090
Why?
Intracranial Arteriovenous Malformations
1
1999
15
0.090
Why?
Models, Genetic
2
1996
161
0.090
Why?
Vascular Diseases
1
2000
70
0.090
Why?
Tantalum
1
1999
5
0.090
Why?
Alloys
1
1999
17
0.090
Why?
Survival Rate
3
2003
618
0.090
Why?
X-Rays
1
1999
28
0.090
Why?
Nickel
1
1999
24
0.090
Why?
Technology, Radiologic
1
1979
17
0.080
Why?
Graft Occlusion, Vascular
1
1999
24
0.080
Why?
Energy Transfer
2
1987
24
0.080
Why?
Ultrasonography, Interventional
1
1999
66
0.080
Why?
Angioplasty, Balloon, Coronary
1
1999
66
0.080
Why?
Titanium
1
1999
137
0.080
Why?
Kaplan-Meier Estimate
2
2008
222
0.080
Why?
Coronary Artery Disease
1
1999
96
0.080
Why?
Prognosis
4
1980
1083
0.080
Why?
Platelet-Derived Growth Factor
1
1998
108
0.070
Why?
Pilot Projects
3
1980
442
0.070
Why?
Coronary Disease
1
1999
258
0.070
Why?
Uterine Cervical Neoplasms
2
1987
125
0.070
Why?
Orbital Neoplasms
2
1985
25
0.070
Why?
Quality Assurance, Health Care
1
1998
123
0.070
Why?
Animals
9
1987
16093
0.070
Why?
Image Processing, Computer-Assisted
1
1998
262
0.070
Why?
Radiographic Image Enhancement
1
1996
58
0.070
Why?
Double-Blind Method
2
2005
992
0.070
Why?
Macrophages
1
1998
346
0.070
Why?
Iridium Radioisotopes
2
1989
15
0.060
Why?
Lymphoma
2
1985
162
0.060
Why?
Neoplasm Staging
2
2003
338
0.060
Why?
Radiography
1
1994
17
0.060
Why?
Phantoms, Imaging
3
1996
141
0.060
Why?
Plastics
3
1982
13
0.060
Why?
Multivariate Analysis
2
2004
541
0.060
Why?
Lung
3
1987
1159
0.060
Why?
Rectum
2
1987
55
0.060
Why?
Head and Neck Neoplasms
1
1994
83
0.060
Why?
Spinal Cord
1
1994
165
0.060
Why?
Bone Neoplasms
2
1980
207
0.050
Why?
Cell Survival
3
1987
551
0.050
Why?
Duodenum
1
1991
33
0.050
Why?
Connective Tissue
1
1991
43
0.050
Why?
Amifostine
1
1991
27
0.050
Why?
Follow-Up Studies
2
1999
1855
0.050
Why?
Quality Control
2
2000
70
0.050
Why?
Rats, Sprague-Dawley
3
1998
986
0.050
Why?
Cholelithiasis
1
1991
14
0.050
Why?
Electrons
2
1982
12
0.050
Why?
Bone and Bones
2
1990
355
0.050
Why?
Organizational Objectives
2
2001
27
0.050
Why?
Neoplasm Recurrence, Local
3
1980
288
0.050
Why?
Biopsy
1
2011
362
0.050
Why?
Graphite
1
1990
2
0.050
Why?
Forecasting
2
2001
177
0.050
Why?
Combined Modality Therapy
2
1999
486
0.050
Why?
Intraoperative Period
2
1999
46
0.040
Why?
Bromodeoxyuridine
1
1989
66
0.040
Why?
Carotid Artery Injuries
2
1998
21
0.040
Why?
Equipment Design
1
1990
248
0.040
Why?
Salvage Therapy
1
2009
59
0.040
Why?
Disease-Free Survival
1
2009
198
0.040
Why?
Diagnosis, Differential
1
2011
874
0.040
Why?
Radiation-Sensitizing Agents
1
1989
75
0.040
Why?
Necrosis
3
1980
103
0.040
Why?
Radiochemistry
1
1987
4
0.040
Why?
Misonidazole
1
1987
9
0.040
Why?
Nitroimidazoles
1
1987
11
0.040
Why?
Urinary Bladder
1
1987
73
0.040
Why?
Comorbidity
1
2009
380
0.040
Why?
Time Factors
4
1980
3182
0.040
Why?
Remission Induction
1
2006
161
0.040
Why?
Disease Progression
1
2009
521
0.040
Why?
Rats
3
1998
4289
0.040
Why?
Recurrence
2
1998
691
0.030
Why?
Clinical Trials as Topic
2
1999
671
0.030
Why?
Serotonin Antagonists
1
2005
20
0.030
Why?
Carboplatin
1
2005
30
0.030
Why?
Doxorubicin
1
2005
107
0.030
Why?
Cyclophosphamide
1
2005
174
0.030
Why?
Pharyngeal Neoplasms
1
1984
7
0.030
Why?
Mouth Neoplasms
1
1984
34
0.030
Why?
Robotics
1
2005
76
0.030
Why?
Subtraction Technique
1
2003
12
0.030
Why?
Taxoids
1
2003
14
0.030
Why?
Prospective Studies
1
2008
1689
0.030
Why?
Motion
1
2003
43
0.030
Why?
Patient Satisfaction
1
2005
226
0.030
Why?
Anastomosis, Surgical
1
2002
67
0.030
Why?
Optics and Photonics
1
2003
43
0.030
Why?
Posture
1
2003
110
0.030
Why?
Scattering, Radiation
2
1979
76
0.030
Why?
Radiation Tolerance
1
2002
89
0.030
Why?
Evaluation Studies as Topic
2
1980
245
0.030
Why?
Sheep
1
2001
93
0.030
Why?
Respiration
1
2002
181
0.020
Why?
Polytetrafluoroethylene
1
2001
37
0.020
Why?
Vascular Patency
1
2001
67
0.020
Why?
Physics
1
2001
6
0.020
Why?
Physical Phenomena
1
2001
6
0.020
Why?
Movement
1
2002
164
0.020
Why?
Decision Making, Computer-Assisted
1
2000
13
0.020
Why?
Thermoluminescent Dosimetry
2
1989
4
0.020
Why?
Artificial Intelligence
1
2000
23
0.020
Why?
Interprofessional Relations
1
2001
76
0.020
Why?
Diagnostic Imaging
1
2001
87
0.020
Why?
Muscles
2
1990
328
0.020
Why?
Soft Tissue Neoplasms
1
1980
46
0.020
Why?
Pubic Bone
1
1999
8
0.020
Why?
Sarcoma
1
1980
63
0.020
Why?
Urethra
1
1999
50
0.020
Why?
Angioplasty, Balloon
1
2000
67
0.020
Why?
Arteriosclerosis
1
2000
92
0.020
Why?
Radiology
1
1999
29
0.020
Why?
Radiopharmaceuticals
1
1999
48
0.020
Why?
Cerebral Hemorrhage
1
1999
61
0.020
Why?
Child, Preschool
2
1991
2660
0.020
Why?
Computers
1
1979
79
0.020
Why?
Quality of Life
1
2003
502
0.020
Why?
Risk Factors
2
1991
2345
0.020
Why?
Cranial Irradiation
1
1998
14
0.020
Why?
Dose-Response Relationship, Drug
1
2001
1117
0.020
Why?
Prostate
1
1999
204
0.020
Why?
Disease Models, Animal
1
2001
956
0.020
Why?
Child
2
1991
4155
0.020
Why?
Cell Adhesion
1
1998
261
0.020
Why?
Analysis of Variance
1
1999
736
0.020
Why?
Probability
1
1997
302
0.020
Why?
Adolescent
2
1991
4766
0.020
Why?
Observer Variation
1
1996
144
0.020
Why?
Cell Line
2
1989
1585
0.020
Why?
Cell Division
1
1998
762
0.020
Why?
Cell Movement
1
1998
361
0.020
Why?
Mediastinum
1
1994
20
0.020
Why?
Photons
1
1994
19
0.020
Why?
Gases
2
1982
36
0.010
Why?
Urinary Diversion
1
1991
15
0.010
Why?
Cells, Cultured
2
1987
2479
0.010
Why?
Brain
1
1999
1214
0.010
Why?
Parenteral Nutrition
1
1991
23
0.010
Why?
Ileum
1
1991
51
0.010
Why?
Dogs
1
1991
468
0.010
Why?
Mathematical Computing
1
1990
11
0.010
Why?
Breast
1
1990
61
0.010
Why?
Surgical Procedures, Operative
1
1990
111
0.010
Why?
Interphase
1
1989
35
0.010
Why?
Etanidazole
1
1987
24
0.010
Why?
Methods
1
1987
221
0.010
Why?
Cricetulus
1
1987
92
0.010
Why?
Cricetinae
1
1987
366
0.010
Why?
Regression Analysis
1
1987
527
0.010
Why?
Infant
1
1991
2278
0.010
Why?
Oropharynx
1
1984
11
0.010
Why?
Neck
1
1984
34
0.010
Why?
Lymphatic Metastasis
1
1984
142
0.010
Why?
Gamma Rays
1
1982
69
0.010
Why?
Magnetics
1
1982
36
0.010
Why?
Osteoradionecrosis
1
1980
3
0.010
Why?
Mucous Membrane
1
1980
37
0.010
Why?
Gastrointestinal Diseases
1
1980
37
0.010
Why?
Central Nervous System Diseases
1
1980
57
0.010
Why?
Skin Diseases
1
1980
120
0.010
Why?

Visualizations


Schell's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department